SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (IRMA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04929353 |
|
Recruitment Status :
Not yet recruiting
First Posted : June 18, 2021
Last Update Posted : June 18, 2021
|
Sponsor:
University Of Perugia
Information provided by (Responsible Party):
Roila Fausto, University Of Perugia
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | June 20, 2023 |
| Estimated Study Completion Date : | June 20, 2024 |